Analysts have been eager to weigh in on the Healthcare sector with new ratings on Owens & Minor (OMI – Research Report), Bruker (BRKR – Research Report) and Gilead Sciences (GILD – Research Report).
Owens & Minor (OMI)
In a report issued on April 17, David Risinger from Leerink Partners reiterated a Hold rating on Owens & Minor, with a price target of $24.00. The company’s shares closed last Friday at $24.79.
According to TipRanks.com, Risinger is a 5-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Owens & Minor with a $24.17 average price target, a 0.6% upside from current levels. In a report issued on April 9, Robert W. Baird also maintained a Hold rating on the stock with a $28.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Bruker (BRKR)
In a report issued on April 17, Puneet Souda from Leerink Partners maintained a Buy rating on Bruker. The company’s shares closed last Friday at $77.76.
According to TipRanks.com, Souda ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Bruker has an analyst consensus of Moderate Buy, with a price target consensus of $88.88.
Gilead Sciences (GILD)
Leerink Partners analyst Daina Graybosch maintained a Hold rating on Gilead Sciences on April 18 and set a price target of $74.00. The company’s shares closed last Friday at $66.76, close to its 52-week low of $65.90.
According to TipRanks.com, Graybosch has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Currently, the analyst consensus on Gilead Sciences is a Moderate Buy with an average price target of $85.63, implying a 29.3% upside from current levels. In a report issued on April 15, Truist Financial also initiated coverage with a Hold rating on the stock with a $82.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on OMI:
